Gains of MYC locus and outcome in patients with diffuse large B‐cell lymphoma treated with R‐CHOP
暂无分享,去创建一个
W. Chan | T. Greiner | J. Vose | G. Gaidano | L. Baldini | E. Zucca | S. Montes-Moreno | A. Ferreri | I. Kwee | F. Bertoni | M. Testoni | M. Mian | A. Chiappella
[1] L. Staudt,et al. Mechanisms of Disease , 2010 .
[2] Philip M Kluin,et al. Double-hit B-cell lymphomas. , 2011, Blood.
[3] W. Chan,et al. Genomic lesions associated with a different clinical outcome in diffuse large B‐Cell lymphoma treated with R‐CHOP‐21 , 2010, British journal of haematology.
[4] S. Barrans,et al. Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] T. Wirth,et al. Advances in the understanding of MYC‐induced lymphomagenesis , 2010, British journal of haematology.
[6] L. Rimsza,et al. Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma , 2010, Haematologica.
[7] R. Gascoyne,et al. MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy. , 2009, Blood.
[8] R. Siebert,et al. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge , 2008, Leukemia.
[9] S. Yoon,et al. MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B‐cell lymphoma (DLBCL), especially in germinal centre‐like B cell (GCB) type , 2008, Histopathology.